Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VR-based Avatar Therapy for Treatment of Auditory Hallucinations in Patients With Schizophrenia 2023-SUD-3446

NCT06505564 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT06505564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06505564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VR-based Avatar Therapy for Treatment of Auditory Hallucinations in Patients With Schizophrenia 2023-SUD-3446
Lead sponsor
Semmelweis University
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2024
Completion date
December 31, 2025
Enrollment
90 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hallucinations, auditory, schizophrenia spectrum and other psychotic disorders